Antiplatelet therapy for coronary stenting;Prescription des antiplaquettaires lors de la pose d'endoprostheses coronaires

Archives des Maladies du Coeur et des Vaisseaux

Volumn 89, Issue 11 SUPPL., 1996, Pages 1515-1520

  Barragan, P ^b   Pietri, P ^b   Villain, P ^b   Silvestri, M ^b   Roquebert, P O ^a  

^a Polyclinique Les Alpilles   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; DEXTRAN 40; DIPYRIDAMOLE; HEPARIN; MONOCLONAL ANTIBODY; TICLOPIDINE;

CORONARY ARTERY DISEASE; ECHOGRAPHY; ENDOPROSTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; ORAL DRUG ADMINISTRATION; RASH; SHORT SURVEY; STENT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY DISEASE; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; ECHOCARDIOGRAPHY; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECURRENCE; STENTS; TICLOPIDINE;

EID: 0029848270     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (42)

1. Rubllan R, Culaud HP, Marin D. Journal officiel de la République Française 1996 ; 7 février: 1967-69.
2. Serruys P, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994 ; 331 : 489-95.
3. Fischman D, Leon M, Baim D et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994 ; 331 : 496-501.
4. Azar A, Detre K, Goldberg S et al. A meta-analysis on the clinical and angiographic outcomes of stents versus PICA in the different coronary vessel sizes in the Benestent-l and Stress- 1/2 trials (abstract). Circulation 1995 ; 92 (suppl I) : 1475.
5. Mintz G, Kovach J. Pichard A et al. Geometric remodeling is the predominant mechanism of clinical restenosis after coronary angioplasty (abstract). J Am Coll Cardiol 1994 ; 23 (suppl I) : 1138 A.
6. Barragan P, Sainsous J, Silvestri M et al. Ticlopidine and subcutaneous neparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 1994 ; 32 : 133-8.
7. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987 ; 316 : 701-6.
8. Roubin G, King S, Douglas J, Lembo N, Robinson K. Intracoronary stenting during percutaneous transluminal coronary angioplasty (abstract). Circulation 1990; 81 (suppl IV): IV 92-V 100.
9. Schatz R. Introduction to intravascular stents. Cordial Clin 1988 ; 6 : 357-72.
10. Schatz R, Palmaz J. Tio F et al. Balloon expandable intracoronary stents in the adult dog. Circulation 1987 ; 76 : 450-7.
11. Serruys P, Strauss B, Beatt K et al. Angiographic follow-up after placement of a self expanding coronary artery stent. N Engl J Med 1991; 324: 13-7.
12. de Jaegere P, Serruys P, Bertrand M et al. Viktor stent implantation in patients with restenosis following balloon angioplasty of a native coronary artery. Am J Cardiol 1992 ; 69 : 598-602.
13. Colombo A, Golberg S, Almagor Y, Maiello L, Finci L. A novel strategy for stent deployment in the treatment of acute or threatened closure complicating balloon coronary angioplasty. Use of short or standard (or both) single or multiple Palmaz-Schatz stents. J Am Coll Cardiol 1993 ; 22 : 1887-91.
14. Balsano F, Rizzon P, Violi F et al. and the STAI Group. Antiplatelet treatment with ticlopidine in unstable angina : a controlled multicenter clinical trial. Circulation 1990 ; 87: 17-26.
15. White CW, Chaitman B, Knudston M, Chisholm R and the ticlopidine study group. Antiplatelet agents are effective in reducing the acute ischemic complications or angioplasty but do not prevent restenosis : results from the ticlopidine trial. Coronary Artery Dis 1991 ; 2: 757-67.
16. Saltiel E, Ward A. Ticlopidine : a review of its pharmacocynamic and pharmacokinetic properties, and therapeutic efficacy in platelet dependent disease states. Drugs 1987 ; 34 : 222-62.
17. Maffrand JP. Nouvelles thérapeutiques antiaqrégantes. Sang Thrombose Vaisseaux 1990 ; 2 : 175-177.
18. Barragan P, Sainsous J, Sitvestri M et al. Étude pilote de l'efficacité de la ticlopidine dans la perméabilité précoce des endoprothèses coronaires. Arch Mal Cœur 1994 ; 87 : 1431-7.
19. Barragan P, Silvestri M, Sainsous J et al. Prevention of subacute occlusion after coronary stenting with ticlopidine regimen without intravascular ultrasound guided stenting (abstract). J Am Coll Cardiol 1995 ; 741-3.
20. Morice MC. Advances in post stenting medication. J Invas Cardiol 1994; 7: A 32-A 35.
21. Carvalho H, Fajadet J, Jordan C et al. A lower rate of complications after Gianturco-Roubin coronary stenting using a new antiplatelet and anticoagulant protocol (abstract). Circulation 1994 ; 90 (suppl I): I 125.
22. Goods C, Al-Shaibi K, Iyer S et al. Flexible coil coronary stenting without anticoagulation or intravascular ultrasound : a prospective observational study. (abstract). Circulation 1995 ; 92 (suppl I) : I 794.
23. Morice MC, Breton C, Bunouf P et al. Coronary stenting without anticoagulation, without intravascular ultrasound. Results of the french registry (abstract). Circulation 1995 ; 92 (suppl I) : 1794.
24. Lablanche JM, Bonnet JL, Grollier G et al. Combined antiplatelet therapy without anticoagulation after stent implantation ; the ticlopidine aspirin stent evaluation (TASTE) study. J Am Coll Cardiol 1996 ; 27 (suppl A): A 137.
25. Hass WK, Easton JD. Ticlopidine, platelets and vascular disease. New York : Springer-Verlag ; 1993.
26. Gregorini L, Marco J, Fajadet J et al. Ticlopidine attenuates postangioplasty thrombin generation (abstract). Circulation 1995 ; 92 (suppl I): 1608.
27. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994 ; 330 : 936-61.
28. Colombo A, Hall P, Nakamura S et al. Intravascular stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995 ; 91 : 1676-988.
29. Goldberg S, Colombo A, Almagor Y et al. Has the introduction of intravascular ultrasound guidance led to different clinical results in the deployment of intracoronary stents ? (abstract). Circulation 1994; 90 (suppl I): 1612.
30. Finet G, Maurincomme E, Douek P et al. Three-layer appearance of the arterial wall in intravascular ultrasound imaging : artifact or reality ? Echocardiography 1994 ; II : 343-63.
31. Schömig A, Neumann F, Kastrati A et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996 ; 334 : 1084-9.
32. Hall P, Nakamura S, Maiello L et al. A randomized comparison of combined ticlopidine and aspirine versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996 ; 93 : 215-22.
33. Mitchel J, Arzin M, Schwedick M et al. Platelet deposition following intracoronary stent placement. Effect of balloon inflation pressure and intravascular ultrasound measurements of stent expansion (abstract). Circulation 1994 ; 90 : 3214.
34. De Jaegere P, Mudra H, Almagor Y et al. In-hospital and 1-month clinical results of an international study testing the concept of IVUS guided optimized stent expansion alleviating the need of systemic anticoagulation (abstract). J Am Coll Caraiol 1996 ; 27 (suppl A) : A 123.
35. Popmo J, Caller B, Ohman E et al. Antithrombotic therapy in patients undergoing coronary angioplasty. Fourth ACCP consensus conference on antithrombotic therapy. Chest 1995 ; 108 (suppl) : S 486-S 501.
36. Lincoff M, Tcheng J, Bass T et al. A multicenter, randomized, double-blind pilot trial of Standart versus low dose weight-ajusted heparin in patients treated with the platelet GP IIb/IIIa receptor antibody c7E3 during PTCA. J Am Coll Cardiol 1996 ; 27 (suppl A) : A80.
37. Monassier JP, Elias J, Raynaud P et al. Results of early (< 24 h) and late (> 24 h) implantation of coronary stents in acute myocardial infarction (abstract). Circulation 1995 ; 92 (suppl I) : I 609.
38. Challapalli R, Eisenberg M, Sigmon K, Lemberger J for the EPIC Investigators. Platelet glycoprotein IIb/IIIa monoclonal antibody (c7E3) reduces distal embolization during percutaneous intervention of saphenous vein grafts (abstract). Circulation 1995 ; 92 (suppl I) : I 607.
39. Muhlestein J, Gomez M, Karagounis L, Andersen J. Rescue Reopro : acute utilisation of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. Circulation 1995 ; 92 (suppl I) : I 607.
40. Cohen I, Burk D, White J. The effects of peptides and monoclonal antibodies that bind to platelet glycoprotein IIb/IIIa a complex on the development of clot tension. blood 1989 ; 73 : 1880-7.
41. Coller B, Peerschke E, Seligsohn U et al. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb/IIIa complex receptor. J Lab Clin Med 1986 ; 107 : 384-92.
42. Serruys P, Emanuelsson H, Van der Giessen W et al. Heparincoated Palmaz-Schatz stent in human coronary arteries. Early outcome of the Benestent-II pilot study. Circulation 1996 ; 93 : 412-22.